Sir John Sulston, Human Genome Project Leader, Remembered For Words On IP And Health R&D 14/03/2018 William New Nobel Prize winner Sir John Sulston passed away on 6 March at the age of 75, and was widely remembered in the press and scientific circles, celebrating his research, his wisdom, and his leadership of the landmark Human Genome Project. Intellectual Property Watch recalls his visionary warning and advice a decade ago about the intellectual property system, investment, and science that is still valuable today. Continue reading -> New IP-Sharing Framework To Accelerate R&D 12/03/2018 Guest contributor Pharmaceutical R&D constantly leads to the generation of new intellectual property (IP), from clinical trial data to libraries of promising compounds. Not all IP assets generated by a company are used in their future R&D. When this happens, companies can choose instead to share them with other third-party researchers, under licensing agreements. The Access to Medicine Foundation has worked with BIO Ventures for Global Health (BVGH) to develop a framework for identifying which IP assets are most difficult for companies to share, yet most likely to speed up R&D of the medicines and vaccines needed by people living in low- and middle-income countries (LMICs), write Clarke B. Cole and Katie Graef. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation 27/02/2018 William New The Wellcome Trust, the London-based biomedical research charity, has issued recommendations for improved scientific collaboration after Brexit, including to establish a formal agreement on research and innovation. This includes continued leadership by the UK on open research, and might include expanding the UK patent box scheme, it says. Continue reading -> Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 Catherine Saez Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New IP-Sharing Framework To Accelerate R&D 12/03/2018 Guest contributor Pharmaceutical R&D constantly leads to the generation of new intellectual property (IP), from clinical trial data to libraries of promising compounds. Not all IP assets generated by a company are used in their future R&D. When this happens, companies can choose instead to share them with other third-party researchers, under licensing agreements. The Access to Medicine Foundation has worked with BIO Ventures for Global Health (BVGH) to develop a framework for identifying which IP assets are most difficult for companies to share, yet most likely to speed up R&D of the medicines and vaccines needed by people living in low- and middle-income countries (LMICs), write Clarke B. Cole and Katie Graef. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation 27/02/2018 William New The Wellcome Trust, the London-based biomedical research charity, has issued recommendations for improved scientific collaboration after Brexit, including to establish a formal agreement on research and innovation. This includes continued leadership by the UK on open research, and might include expanding the UK patent box scheme, it says. Continue reading -> Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 Catherine Saez Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation 27/02/2018 William New The Wellcome Trust, the London-based biomedical research charity, has issued recommendations for improved scientific collaboration after Brexit, including to establish a formal agreement on research and innovation. This includes continued leadership by the UK on open research, and might include expanding the UK patent box scheme, it says. Continue reading -> Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 Catherine Saez Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Wellcome Trust Report Recommends UK-EU Agreement On Research & Innovation 27/02/2018 William New The Wellcome Trust, the London-based biomedical research charity, has issued recommendations for improved scientific collaboration after Brexit, including to establish a formal agreement on research and innovation. This includes continued leadership by the UK on open research, and might include expanding the UK patent box scheme, it says. Continue reading -> Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 Catherine Saez Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Swiss Panel Looks At Value-Based Drug Pricing, Link Between R&D And Prices 26/02/2018 Catherine Saez Some products are too cheap, generic drug companies do not invest in them because they do not make enough money out of them. Others seem astronomically expensive, and are said to include the costs of all research, successes and failures alike. Panellists at a recent Swiss-organised expert event in Bern concurred that something must done about pricing, and explored some surprising ways to do it. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> “We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“We Count On The US To Maintain Its Commitment” – Global Fund On US Budget Cut 22/02/2018 William New Some international organisations are having to gear up to address proposed cuts to their budgets announced this month by the United States, in many cases the major funder. Geneva-based health agencies this week responded that they are counting on the US not to make significant cuts. Continue reading -> US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US 2019 Budget Proposal Shows Stable Funding For WIPO, WTO, WHO, ITU 19/02/2018 William New While the Trump administration has taken aim overall at US contributions to international organisations since taking office last year, the budget proposal it put forward last week would roughly maintain last year's lower levels for a range of Geneva-based agencies without making further cuts. Others did not fare as well. Continue reading -> Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Indian Pharma Industry Disputes US Industry IP Index 15/02/2018 William New The United States Chamber of Commerce industry group recently issued its annual global IP index, analysing intellectual property protection in 50 countries, as a prelude to the annual US government list of countries seen as not adequately protection US companies' IP rights. Now an Indian industry group has issued a counter-statement to the Chamber index, calling it a "tirade" and "self-serving". Continue reading -> CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CARB-X Announces First Award Of 2018; Seeks Partners For Antibacterial Research 15/02/2018 William New CARB-X, the private-public partnership for research on antimicrobial resistance, today announced its first award of 2018, nearly $2 million for the development of a new class of antibiotics. Meanwhile, the group has announced it is seeking to partner with accelerator organisations to build its pipeline of early development research projects. It also announced a study that called for a new global approach and greater financial incentives for antibiotic research. Continue reading -> Posts navigation Older postsNewer posts